X0306 4 2017-02-24 1 0000892160 DERMA SCIENCES, INC. DSCI 0001483051 Hewlett Brett WILSON ROAD SOUTH PRIVATE BAG 1 TE PUKE Q2 3189 NEW ZEALAND 1 0 0 0 Common Stock 2017-02-24 4 D 0 51250 D 0 D Common Stock 2017-02-24 4 D 0 17500 A 17500 D Stock Option (right to buy) 5.12 2017-02-24 4 D 0 20000 0 D Common Stock 20000 0 D Restricted Stock Units 2017-02-24 4 D 0 17500 0 D Common Stock 17500 0 D Pursuant to the terms of the Agreement and Plan of Merger, dated January 10, 2017, by and among the Issuer, Integra Derma, Inc. and Integra LifeSciences Holdings Corporation (the "Merger Agreement"), as of the Effective Time (as defined in the Merger Agreement), the shares of the Issuer's common stock were converted into the right to receive $7.00 per share to the reporting person in cash. Represents shares of the Issuer's common stock received upon the vesting of 17,500 restricted stock units, as described herein. Represents the weighted average exercise price for in-the-money stock options, as described in a Schedule TO and the Issuer's Schedule 14D-9, each as filed with the Securities and Exchange Commission on January 25, 2017, pursuant to which Integra Derma, Inc. offered to purchase all of the Issuer's common stock for $7.00 per share (the "Offer"). In connection with the expiration of the Offer and the subsequent closing of the merger pursuant to the terms of the Merger Agreement, all outstanding stock options became fully vested and exercisable on such date. Each stock option held by the reporting person was then cancelled in exchange for a cash payment representing the difference between the exercise price of such option and $7.00 per share, payable without any interest thereon and subject to any required tax withholdings. Upon the Effective Time, the restricted stock units were converted into the right to receive an amount in cash equal to $7.00 with respect to each share of common stock underlying such award, payable without any interest thereon and subject to any required tax withholdings. The options were originally granted in consideration of the reporting person's services to the Issuer and without payment of consideration. The restricted stock units were originally granted in consideration of the reporting person's services to the Issuer and without payment of consideration. /s/ Brett Hewlett 2017-02-24